Search
Canopy Growth Corp
CGCAdd to Watchlist
0.967USD
+0.024+2.49%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
408.22MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Canopy Growth Corp is 6.67, ranking 126 out of 157 in the Pharmaceuticals industry. The average price target is 3.65, with a high of 3.65 and a low of 3.65.
Analyst Rating
Based on
3
analysts
Hold
Current Rating
1.800
Target Price
+86.10%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Canopy Growth Corp
CGC
3
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Canopy Growth Corp's expected revenue for the next quarter?
Canopy Growth Corp's expected revenue is 58.26M.
What is Canopy Growth Corp's price target?
Analysts forecast that Canopy Growth Corp's price target is USD 3.65, with the highest forecast at USD 3.65 and the lowest forecast at USD 3.65.
How have Canopy Growth CorpCGC's recent earnings per share performed?
The market expectation was USD -0.29, while Canopy Growth CorpCGC's earnings per share (EPS) for the previous quarter was USD -0.13. EPS for the next quarter is expected at USD -0.07.
What is the analyst rating for Canopy Growth Corp?
Based on the ratings of Canopy Growth Corp's stock from 3 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
